Home > Insider Trading > Filing (0001179110-11-009430)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199632	J William Bolt	C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923	Svp, Qa And Regulatory Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.01 Par Value	Disposition	2011-06-07	3,607	$17.12	94,787	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$15.56	2004-06-28	2010-06-28	40,000	40,000	Direct
Common Stock	Stock Option (right to buy)	$24.12	2005-06-22	2011-06-22	25,000	25,000	Direct
Common Stock	Stock Option (right to buy)	$6.75	2004-06-25	2012-06-25	50,000	50,000	Direct
Common Stock	Stock Option (right to buy)	$5.11	2005-06-25	2013-06-25	16,000	16,000	Direct
Common Stock	Stock Option (right to buy)	$12.30	2005-07-01	2014-07-01	18,000	18,000	Direct
Common Stock	Stock Option (right to buy)	$9.36	2006-06-08	2015-06-08	30,000	30,000	Direct
Common Stock	Stock Option (right to buy)	$13.57	2007-06-01	2016-06-01	20,000	20,000	Direct
Common Stock	Stock Option (right to buy)	$11.27	2008-05-30	2017-05-30	8,000	8,000	Direct
Common Stock	Stock option (right to buy)	$13.80	2009-05-23	2018-05-23	9,666	9,666	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	50,000	50,000	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-03-31	2019-05-28	18,000	18,000	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	30,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2010-06-28	40,000	40,000	Direct
2011-06-22	25,000	25,000	Direct
2012-06-25	50,000	50,000	Direct
2013-06-25	16,000	16,000	Direct
2014-07-01	18,000	18,000	Direct
2015-06-08	30,000	30,000	Direct
2016-06-01	20,000	20,000	Direct
2017-05-30	8,000	8,000	Direct
2018-05-23	9,666	9,666	Direct
2019-05-28	50,000	50,000	Direct
2019-05-28	18,000	18,000	Direct
2020-06-03	30,000	25,000	Direct

Footnotes

Options were fully exercisable on the date shown.
Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 1998 Equity Incentive Plan.
Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
These options became fully exerciseable on March 31, 2010.
Includes 9,000 shares represented by a performance share award for restricted stock units pursuant to which one third of the shares will be issued to the reporting person on each of May 26, 2012, May 26, 2013 and May 26, 2014, so long as he continues to be employed by the issuer on the vesting dates.
Sale of common stock pursuant to reporting owner's 10(b)5-1 plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $16.93 and $17.21. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.